A NOVEL INHIBITOR OF RIBOSOME BIOGENESIS WITH ANTITUMOR ACTIVITY IN PRECLINICAL MODELS OF PROSTATE CANCER

$768,263FY2022Department of the ArmyDOD

University Of Melbourne, Melbourne

Investigators